Radiation Oncology

Papers
(The H4-Index of Radiation Oncology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Outcome of patients with soft tissue sarcomas of the extremities and trunk treated by (neo)adjuvant intensity modulated radiation therapy with curative intent60
Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia60
A multifunctional targeted nano-delivery system with radiosensitization and immune activation in glioblastoma58
Pamiparib as consolidation treatment after concurrent chemoradiotherapy of limited-stage small cell lung cancer: a single-arm, open-label phase 2 trial54
Dosimetric comparison of two dose expansion methods in intensity modulated radiotherapy for breast cancer54
A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy52
Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)50
Compliance of volunteers in a fully-enclosed patient rotation system for MR-guided radiation therapy: a prospective study43
CircRNA_101491 regulated the radiation sensitivity of esophageal squamous cell carcinomas via sponging miR-125a-5p43
Using meta-analysis and CNN-NLP to review and classify the medical literature for normal tissue complication probability in head and neck cancer43
Correction to: 125I seeds irradiation inhibits tumor growth and induces apoptosis by Ki-67, P21, survivin, livin and caspase-9 expression in lung carcinoma xenografts41
Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery38
Efficacy and safety of tyrosine kinase inhibitors with thoracic radiotherapy for patients with oncogene-mutated non-small cell lung cancer: a meta-analysis38
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov35
Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy34
Knowledge-based DVH estimation and optimization for breast VMAT plans with and without avoidance sectors33
Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer33
Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prost33
Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study33
Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer30
The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review30
Preoperative short-course radiotherapy followed by consolidation chemotherapy for treatment with locally advanced rectal cancer: a meta-analysis30
125I seed brachytherapy for non-central pelvic recurrence of cervical cancer after external beam radiotherapy30
Radiotherapy refusal in breast cancer with breast-conserving surgery29
The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma29
Comparison of deep learning networks for fully automated head and neck tumor delineation on multi-centric PET/CT images28
Evaluating differences in respiratory motion estimates during radiotherapy: a single planning 4DMRI versus daily 4DMRI27
A survey of cancer patients’ interest in undertaking exercise to promote relaxation during radiotherapy for breast cancer and metastatic cancer27
Clinical features and risk factors for interstitial lung disease spreading in low-dose irradiated areas after definitive radiotherapy with or without durvalumab consolidation therapy for patients with27
0.050111055374146